Gainers & Losers Of The Day: MNTA, BLCM, VSAR, TENX, DMTX...

Tenax Therapeutics Inc. lost more than 76% of its stock value, following the failure of its phase III LEVO-CTS trial.

from RTT - Biotech http://ift.tt/2kpTDYQ
via IFTTT